Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1971 3
1974 1
1975 1
1976 1
1977 1
1982 1
1983 1
1985 1
1986 2
1987 7
1988 4
1989 5
1990 5
1991 5
1992 11
1993 10
1994 16
1995 14
1996 24
1997 39
1998 38
1999 54
2000 78
2001 96
2002 100
2003 129
2004 125
2005 137
2006 176
2007 185
2008 211
2009 208
2010 223
2011 275
2012 272
2013 286
2014 402
2015 596
2016 640
2017 627
2018 815
2019 904
2020 1192
2021 1430
2022 1506
2023 1507
2024 1719
2025 136

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,239 results

Results by year

Filters applied: . Clear all
Page 1
Glioma-on-a-Chip Models.
Ustun M, Rahmani Dabbagh S, Ilci IS, Bagci-Onder T, Tasoglu S. Ustun M, et al. Micromachines (Basel). 2021 Apr 26;12(5):490. doi: 10.3390/mi12050490. Micromachines (Basel). 2021. PMID: 33926127 Free PMC article.
KOC is a novel molecular indicator of malignancy.
Mueller F, Bommer M, Lacher U, Ruhland C, Stagge V, Adler G, Gress TM, Seufferlein T. Mueller F, et al. Br J Cancer. 2003 Mar 10;88(5):699-701. doi: 10.1038/sj.bjc.6600790. Br J Cancer. 2003. PMID: 12618877 Free PMC article.
Aspirates were examined by cytology and by a KOC RT-PCR assay. KOC expression was a highly sensitive and specific indicator of malignancy. The KOC assay could be useful to facilitate screening for malignant disease and to improve the diagnostic accuracy of FN …
Aspirates were examined by cytology and by a KOC RT-PCR assay. KOC expression was a highly sensitive and specific indicator of …
A systematic review of kidney-on-a-chip-based models to study human renal (patho-)physiology.
Nguyen VVT, Gkouzioti V, Maass C, Verhaar MC, Vernooij RWM, van Balkom BWM. Nguyen VVT, et al. Dis Model Mech. 2023 Jun 1;16(6):dmm050113. doi: 10.1242/dmm.050113. Epub 2023 Jun 19. Dis Model Mech. 2023. PMID: 37334839 Free PMC article.
We conclude that KoC models have evolved to complex models capable of mimicking systemic (patho-)physiological processes. Commercial chips and human induced pluripotent stem cells and organoids are important for KoC models to study disease mechanisms and assess drug …
We conclude that KoC models have evolved to complex models capable of mimicking systemic (patho-)physiological processes. Commercial …
Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system.
Chatterjee E, Rodosthenous RS, Kujala V, Gokulnath P, Spanos M, Lehmann HI, de Oliveira GP, Shi M, Miller-Fleming TW, Li G, Ghiran IC, Karalis K, Lindenfeld J, Mosley JD, Lau ES, Ho JE, Sheng Q, Shah R, Das S. Chatterjee E, et al. JCI Insight. 2023 Nov 22;8(22):e165172. doi: 10.1172/jci.insight.165172. JCI Insight. 2023. PMID: 37707956 Free PMC article.
Whether circulating extracellular vesicles (EVs) and their RNA cargo directly impact its pathogenesis remains unclear.METHODSWe investigated the role of circulating EVs from patients with CRS on renal epithelial/endothelial cells using a microfluidic kidney-on-chip (KOC) m …
Whether circulating extracellular vesicles (EVs) and their RNA cargo directly impact its pathogenesis remains unclear.METHODSWe investigated …
In Response.
Gürkan Y, Şimşek D, Güllü B, Manici M, Darçin K, Yürük B, Eren İ, Demirhan M. Gürkan Y, et al. A A Pract. 2024 Aug 15;18(8):e01836. doi: 10.1213/XAA.0000000000001836. eCollection 2024 Aug 1. A A Pract. 2024. PMID: 39145586 No abstract available.
Biomedical optical fibers.
Rezapour Sarabi M, Jiang N, Ozturk E, Yetisen AK, Tasoglu S. Rezapour Sarabi M, et al. Lab Chip. 2021 Feb 23;21(4):627-640. doi: 10.1039/d0lc01155j. Lab Chip. 2021. PMID: 33449066 Review.
Bioprinting in Microgravity.
Rezapour Sarabi M, Yetisen AK, Tasoglu S. Rezapour Sarabi M, et al. ACS Biomater Sci Eng. 2023 Jun 12;9(6):3074-3083. doi: 10.1021/acsbiomaterials.3c00195. Epub 2023 May 8. ACS Biomater Sci Eng. 2023. PMID: 37155968 Free PMC article. Review.
Organs-on-chip technology: a tool to tackle genetic kidney diseases.
G Valverde M, Faria J, Sendino Garví E, Janssen MJ, Masereeuw R, Mihăilă SM. G Valverde M, et al. Pediatr Nephrol. 2022 Dec;37(12):2985-2996. doi: 10.1007/s00467-022-05508-2. Epub 2022 Mar 14. Pediatr Nephrol. 2022. PMID: 35286457 Free PMC article. Review.
In this review, we summarize the major kidney-on-chip (KOC) configurations and present the most recent studies on the in vitro representation of genetic kidney diseases using KOC-driven strategies....
In this review, we summarize the major kidney-on-chip (KOC) configurations and present the most recent studies on the in vitro repres …
Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel.
Ali A, Brown V, Denley S, Jamieson NB, Morton JP, Nixon C, Graham JS, Sansom OJ, Carter CR, McKay CJ, Duthie FR, Oien KA. Ali A, et al. BMC Clin Pathol. 2014 Jul 23;14:35. doi: 10.1186/1472-6890-14-35. eCollection 2014. BMC Clin Pathol. 2014. PMID: 25071419 Free PMC article.
Using 20% positive cells as a cut-off achieved higher sensitivity/specificity values: KOC 84%/100%; S100P 83%/100%; mesothelin 88%/92%; and MUC1 89%/63%. Analysis of a panel of KOC, S100P and mesothelin achieved 100% sensitivity and 99% specificity if at least 2 bio …
Using 20% positive cells as a cut-off achieved higher sensitivity/specificity values: KOC 84%/100%; S100P 83%/100%; mesothelin 88%/92 …
12,239 results
You have reached the last available page of results. Please see the User Guide for more information.